SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133624
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d244531ddefa14a.htm DEFA14A 10703
2 GRAPHIC g244531g00s01.jpg GRAPHIC 332097
3 GRAPHIC g244531g00s02.jpg GRAPHIC 198781
  Complete submission text file 0001193125-22-133624.txt   743247
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37465 | Film No.: 22875318
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences